Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression

Biochemical and Biophysical Research Communications

Volumn 343, Issue 1, 2006, Pages 69-76

  Sougioultzis, Stavros ^a   Simeonidis, Simos ^a   Bhaskar, K Ramakrishnan ^a   Chen, Xinhua ^a   Anton, Pauline M ^a   Keates, Sarah ^a   Pothoulakis, Charalabos ^a   Kelly, Ciarán P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Colitis; Infectious diarrhea; Intestinal inflammation; Probiotic

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES BOULARDII; THERMOSTABILITY; TRANSACTIVATION;

CELLS, CULTURED; CYTOKINES; DNA; GASTRIC MUCOSA; GENE EXPRESSION; HEAT; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; INTESTINAL MUCOSA; NF-KAPPA B; POLYSACCHARIDES; PROTEIN TRANSPORT; SACCHAROMYCES; SOLUBILITY; TRANSCRIPTION FACTOR RELA;

SACCHAROMYCES BOULARDII;

EID: 33645104228     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.080     Document Type: Article

References (35)

1. G.W. Elmer, C.M. Surawicz, and L.V. McFarland Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections JAMA 275 11 1996 870 876
2. A. Sullivan, and C.E. Nord The place of probiotics in human intestinal infections Int. J. Antimicrob. Agents 20 5 2002 313 319
3. M. Guslandi, G. Mezzi, M. Sorghi, and P.A. Testoni Saccharomyces boulardii in maintenance treatment of Crohn's disease Dig. Dis. Sci. 45 7 2000 1462 1464
4. C. Pothoulakis, C.P. Kelly, M.A. Joshi, N. Gao, and C.J. O'Keane Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum Gastroenterology 104 4 1993 1108 1115
5. I. Castagliuolo, M.F. Riegler, L. Valenick, J.T. LaMont, and C. Pothoulakis Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa Infect. Immun. 67 1 1999 302 307
6. D. Czerucka, and P. Rampal Experimental effects of Saccharomyces boulardii on diarrheal pathogens Microbes Infect. 4 7 2002 733 739
7. C. Jobin, and R.B. Sartor The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection Am. J. Physiol. Cell Physiol. 278 3 2000 C451 C462
8. S. Simeonidis, D. Stauber, G. Chen, W.A. Hendrickson, and D. Thanos Mechanisms by which IkappaB proteins control NF-kappaB activity Proc. Natl. Acad. Sci. USA 96 1 1999 49 54
9. K.A. Roebuck Regulation of interleukin-8 gene expression J. Interferon Cytokine Res. 19 5 1999 429 438
10. S. Dahan, G. Dalmasso, V. Imbert, J.F. Peyron, P. Rampal, and D. Czerucka Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells Infect. Immun. 71 2 2003 766 773
11. S. Keates, S. Sougioultzis, A.C. Keates, D. Zhao, R.M. Peek Jr., and L.M. Shaw cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells J. Biol. Chem. 276 51 2001 48127 48134
12. A.T. Ting, F.X. Pimentel-Muinos, and B. Seed RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis EMBO J. 15 22 1996 6189 6196
13. M. Warny, A.C. Keates, S. Keates, I. Castagliuolo, J.K. Zacks, and S. Aboudola p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis J. Clin. Invest. 105 8 2000 1147 1156
14. S. Simeonidis, I. Castagliuolo, A. Pan, J. Liu, C.C. Wang, and A. Mykoniatis Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter Proc. Natl. Acad. Sci. USA 100 5 2003 2957 2962
15. M. Merika, A.J. Williams, G. Chen, T. Collins, and D. Thanos Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription Mol. Cell 1 2 1998 277 287
16. S. Keates, A.C. Keates, E. Mizoguchi, A. Bhan, and C.P. Kelly Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis Am. J. Physiol. 273 1, Pt. 1 1997 G75 G82
17. A.H. Cory, T.C. Owen, J.A. Barltrop, and J.G. Cory Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture Cancer Commun. 3 7 1991 207 212
18. K.R. Bhaskar, and L. Reid Application of density gradient methods for the study of mucus glycoprotein and other macromolecular components of the sol and gel phases of asthmatic sputa J. Biol. Chem. 256 14 1981 7583 7589
19. M. Dubois, K. Gilles, J. Hamilton, P. Rebers, and F. Smith Colorimetric method for determination of sugars and related substances Anal. Chem. 28 3 1956 350 356
20. J.D. Fox, and J.F. Robyt Miniaturization of three carbohydrate analyses using a microsample plate reader Anal. Biochem. 195 1 1991 93 96
21. K.R. Bhaskar, B.S. Turner, S.A. Grubman, D.M. Jefferson, and J.T. LaMont Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (delta-f508) cystic fibrosis transmembrane conductance regulator Hepatology 27 1 1998 7 14
22. M.T. Abreu, P. Vora, E. Faure, L.S. Thomas, E.T. Arnold, and M. Arditi Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide J. Immunol. 167 3 2001 1609 1616
23. I. Castagliuolo, J.T. Lamont, S.T. Nikulasson, and C. Pothoulakis Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum Infect. Immun. 64 12 1996 5225 5232
24. D. Czerucka, I. Roux, and P. Rampal Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells Gastroenterology 106 1 1994 65 72
25. A. Ben Baruch, D.F. Michiel, and J.J. Oppenheim Signals and receptors involved in recruitment of inflammatory cells J. Biol. Chem. 270 20 1995 11703 11706
26. D. Elewaut, J.A. DiDonato, J.M. Kim, F. Truong, L. Eckmann, and M.F. Kagnoff NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria J. Immunol. 163 3 1999 1457 1466
27. C. Jobin, S. Haskill, L. Mayer, A. Panja, and R.B. Sartor Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells J. Immunol. 158 1 1997 226 234
28. D. Czerucka, S. Dahan, B. Mograbi, B. Rossi, and P. Rampal Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells Infect. Immun. 68 10 2000 5998 6004
29. R.J. Xavier, and D.K. Podolsky Microbiology. How to get along-friendly microbes in a hostile world Science 289 5484 2000 1483 1484
30. A.S. Neish, A.T. Gewirtz, H. Zeng, A.N. Young, M.E. Hobert, and V. Karmali Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination Science 289 5484 2000 1560 1563
31. E.O. Petrof, K. Kojima, M.J. Ropeleski, M.W. Musch, Y. Tao, and C. De Simone Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition Gastroenterology 127 5 2004 1474 1487
32. M. Karin, and Y. Ben Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu. Rev. Immunol. 18 2000 621 663
33. Y. Yamamoto, and R.B. Gaynor Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer J. Clin. Invest. 107 2 2001 135 142
34. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 5174 1994 956 959
35. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 5234 1995 286 290